Standard BioTools Inc. Enters Agreement to Sell Microfluidics Business to ARCHIMED
Acquiring Company
Standard BioTools
Acquired Company
ARCHIMED
San Francisco
LyonBiotechnologyHealth CareFinancial ServicesHealth CareVenture CapitalMedicalventure capital & private equityDescription
On October 5, 2026, Standard BioTools Inc. announced that it has entered into a definitive agreement for the sale of its Microfluidics business to ARCHIMED. The transaction is anticipated to close in approximately 30 days, pending customary closing conditions. This strategic move is part of Standard BioTools' focus on optimizing its business operations.
Fundz sees it the moment Standard BioTools makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired ARCHIMED?
ARCHIMED was acquired by Standard BioTools, based in San Francisco. The deal was reported on October 5, 2026. Standard BioTools Inc. is a biotechnology company engaged in the development of innovative tools and technologies for life science research and clinical applications. Standard BioTools is publicly traded (LAB) and operates in Biotechnology.
When did Standard BioTools acquire ARCHIMED?
Standard BioTools's acquisition of ARCHIMED was reported on October 5, 2026. On October 5, 2026, Standard BioTools Inc. announced that it has entered into a definitive agreement for the sale of its Microfluidics business to ARCHIMED. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does ARCHIMED do?
ARCHIMED is a private equity firm focusing on the healthcare sector. It invests in and supports companies that provide innovative solutions in medical technology and services. It is privately held, operating in Financial Services, and is based in Lyon.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.